Navigation Links
Soligenix and Intrexon Pursue Melioidosis Therapy Through Worldwide Exclusive Collaboration
Date:5/1/2013

x™ has been shown to be well tolerated and immunogenic in two Phase 1 clinical trials in healthy volunteers. Both RiVax™ and VeloThrax™ are currently the subject of a $9.4 million National Institute of Allergy and Infectious Diseases (NIAID) grant supporting development of Soligenix's new vaccine heat stabilization technology known as ThermoVax™. Soligenix is also developing OrbeShield™ for the treatment of gastrointestinal acute radiation syndrome (GI ARS) under a $600,000 NIAID Small Business Innovation Research (SBIR) grant. OrbeShield™ has previously demonstrated statistically significant preclinical survival results in two separate canine GI ARS studies funded by the NIAID.

For further information regarding Soligenix, Inc., please visit the Company's website at www.soligenix.com.

This press release contains forward-looking statements that reflect Soligenix, Inc.'s current expectations about its future results, performance, prospects and opportunities. Statements that are not historical facts, such as "anticipates," "believes," "intends," "potential," or similar expressions, are forward-looking statements. These statements are subject to a number of risks, uncertainties and other factors that could cause actual events or results in future periods to differ materially from what is expressed in, or implied by, these statements. Soligenix cannot assure you that it will be able to successfully develop or commercialize products based on its technology, particularly in light of the significant uncertainty inherent in developing vaccines against bioterror threats conducting preclinical and clinical trials of vaccines, obtaining regulatory approvals and manufacturing vaccines, that product development and commercialization efforts will not be reduced or discontinued due to difficulties or delays in clinical trials or due to lack of progress or positive results from research and de
'/>"/>

SOURCE Soligenix, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Soligenix to Present at World Vaccine Congress & Expo
2. Soligenix Receives IND Clearance from FDA to Initiate Clinical Program to Evaluate SGX942 for the Treatment of Oral Mucositis
3. Soligenix to Present at 15th Annual BIO CEO & Investor Conference
4. Soligenix Announces Formation of Oral Mucositis Medical Advisory Board
5. FDA Grants Soligenix Fast Track Designation for OrbeShield(TM) for the Reduction of Mortality Associated with Gastrointestinal Acute Radiation Syndrome (GI ARS)
6. Soligenix Reports Third Quarter 2012 Financial Results and Highlights Recent Accomplishments
7. FDA Grants Soligenix Fast Track Designation for SGX203 for the Treatment of Pediatric Crohns Disease
8. Soligenix Announces Issuance of US Patent for Topically Active Steroids to Treat Inflammatory Gastrointestinal Disorders
9. Soligenix Reports Second Quarter 2012 Financial Results and Highlights Recent Accomplishments
10. Soligenix Reports First Quarter 2012 Financial Results and Highlights Recent Accomplishments
11. Soligenix Announces Further Progress with ThermoVax™ for Long-Term Vaccine ThermoStability
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... 4, 2015  Pharmaceutical companies today rely heavily ... Medical Specialists (FBMS) to build and strengthen vital ... leaders in critical therapeutic areas. ... companies are expanding the critical MSL function into ... corporate objectives and to achieve regional consistency, compliance, ...
(Date:9/4/2015)... 4, 2015  Essilor is pleased to announce the ... against the eyestrain that comes with the constant connection ... as an everyday pair of glasses to provide comfort ... on smart phones, tablets and computers for hours at ... require a prescription but also those who currently wear ...
(Date:9/4/2015)... SAN DIEGO , Sept. 4, 2015  Orexigen® Therapeutics, ... present a corporate overview at the Wells Fargo Securities 2015 ... is scheduled for Thursday, September 10 th at 2:30 ... a replay of the discussion, please visit the Investors section ... replay will be available for 14 days after the event.  ...
Breaking Medicine Technology:New Study Presents Tactics and Insights on How to Effectively Globalize Medical Science Liaison Programs in the Pharmaceutical Industry 2Essilor Launches New Eyezen Glasses Specifically Designed For A Digital Focused Audience 2
(Date:9/4/2015)... Los Angeles, CA (PRWEB) , ... September 04, 2015 , ... ... new material has been developed that changes color when subjected to an impact force ... article notes, could be implemented in helmets or other sporting equipment so that coaches ...
(Date:9/4/2015)... ... September 04, 2015 , ... The Schmidt National Law ... De La Paz. , Schmidt National Law Group, a leading firm in mass-tort ... California against Bayer Corp., Bayer Essure, Inc., and other Bayer affiliates for injuries alleged ...
(Date:9/4/2015)... Winston-Salem, NC (PRWEB) , ... September 04, 2015 ... ... address the Consumer Health Products Association (CHPA) joint meeting of its Product, Quality ... landscape for hazardous waste handling rules constantly evolving in the consumer goods industry, ...
(Date:9/4/2015)... HI (PRWEB) , ... September 04, 2015 , ... “Getting ... best ways for couples to explore, revitalize and strengthen their ‘couple-ness,’” says Jean ... his team at Four Seasons Resort Maui, the island’s only Forbes Five Star resort ...
(Date:9/4/2015)... ... September 04, 2015 , ... The conference program for ... Florida October 9-10, 2015 at the Diplomat Resort & Spa has been announced ... and researchers at the top of their field and will be presenting sessions ...
Breaking Medicine News(10 mins):Health News:New Article on Head Injury Detection Technology Highlights Implications for Head Injury Detection in Sports, says The Law Offices of Burg & Brock 2Health News:Schmidt National Law Group Files First Bayer Essure® Lawsuit in California 2Health News:Inmar Experts To Address OTC Manufacturers’ Session on Hazardous Waste and Handling at CHPA Meeting 2Health News:Inmar Experts To Address OTC Manufacturers’ Session on Hazardous Waste and Handling at CHPA Meeting 3Health News:Couples Season at Four Seasons Resort Maui Begins This Week With Best Hotel Rates of the Year through November 2Health News:Couples Season at Four Seasons Resort Maui Begins This Week With Best Hotel Rates of the Year through November 3Health News:Integrative Healthcare Symposium Focus On: The Microbiome Conference Program Announced 2
... ... Institute for Medical Research who is trying to identify some of the factors that play into ... Manhasset, ... or why they couldn,t - you may get an equal number of different answers. Christine Metz, ...
... CHERRY HILL, N.J., Aug. 27 Nuvilex, Inc. (OTC Bulletin ... ("Last Shot") video commercial will begin airing on Monday, August ... emerging Last Shot brand awareness campaign that will ultimately include ... The video will initially be introduced to the public through ...
... Smokers, tongues have reduced blood supply, study finds ... addition to the many well-known ways that smoking cigarettes ... that smoking dampens the ability to taste. , In ... taste threshold of 62 Greek participants. Applying an electrical ...
... , WEST PALM BEACH, Fla., Aug. 27 ... has added a new module designed to help physicians manage their ... and employee motivation are two of the most important yet infrequently ... , , Leading this new module is Atesh ...
... , , Online Resource ... Va., Aug. 27 Parents, teachers, and school officials are anxiously ... as Swine Flu. Declared a pandemic by the World Health Organization, ... across the country. , , To help both ...
... Aug. 27 The Office of the President and other White ... a prominent physician group, and a non-profit advocate for inner-city poor. ... collected information on political speech ," thereby illegally using the power ... health care reform, according to the complaint filed in District Court ...
Cached Medicine News:Health News:Scientist at The Fienstein Instute for Medical Research Discovers Quitting Smoking Promotes Anti-Inflammatory Response 2Health News:Scientist at The Fienstein Instute for Medical Research Discovers Quitting Smoking Promotes Anti-Inflammatory Response 3Health News:Nuvilex Introduces Last Shot Hangover Remedy(TM) Video 2Health News:Everything Teachers and Parents Need to Know About Swine Flu 2Health News:White House Sued Over Free Speech Violations In Healthcare Battle: Doctor & Patient Groups Say White House Intended to Shut Up Opponents 2
... offer, you can prepare for ... P2 and P10 are ideal ... P100 is perfect for buffers. ... which are especially recommended for ...
... The RapidPCP test is an immunochromatography ... It is,designed for qualitative determination of ... cut-off level of 25 ng/mL. This ... the point of care location,and is ...
... The Bio-Quant Rapid Opiate II Rapid ... vitro test. It is designed for qualitative ... urine specimens. The presence of morphine in ... can be detected. This assay has not ...
... DOA Panel Test is an ... vitro test. It is designed,for ... in human urine specimens. This ... the point of care location ...
Medicine Products: